AustralianSuper Pty Ltd Sells 22,111 Shares of CME Group Inc. $CME

AustralianSuper Pty Ltd lessened its holdings in CME Group Inc. (NASDAQ:CME) by 15.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 117,286 shares of the financial services provider’s stock after selling 22,111 shares during the period. AustralianSuper Pty Ltd’s holdings in CME Group were worth $32,028,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Asset Dedication LLC grew its position in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. FNY Investment Advisers LLC purchased a new position in CME Group in the 4th quarter worth approximately $27,000. Legacy Wealth Managment LLC ID boosted its stake in CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares during the period. Global Wealth Strategies & Associates boosted its stake in CME Group by 1,250.0% in the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 100 shares during the period. Finally, Anfield Capital Management LLC grew its holdings in CME Group by 197.4% during the 4th quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after buying an additional 75 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel directly owned 7,192 shares in the company, valued at $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the sale, the director directly owned 43,007 shares of the company’s stock, valued at $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 7,791 shares of company stock worth $2,489,421 over the last ninety days. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Erste Group Bank upgraded shares of CME Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, March 5th. Rothschild & Co Redburn cut their target price on shares of CME Group from $340.00 to $316.00 and set a “neutral” rating for the company in a research note on Monday, April 27th. Jefferies Financial Group reduced their price target on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Argus reiterated a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. Finally, JPMorgan Chase & Co. increased their price objective on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a report on Thursday, April 16th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $305.29.

CME Group Stock Up 0.2%

NASDAQ CME opened at $297.70 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $107.87 billion, a P/E ratio of 25.40, a P/E/G ratio of 3.59 and a beta of 0.23. CME Group Inc. has a one year low of $257.17 and a one year high of $329.16. The stock has a 50 day moving average price of $298.49 and a 200-day moving average price of $287.99.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the prior year, the firm earned $2.80 earnings per share. CME Group’s revenue was up 14.5% on a year-over-year basis. As a group, equities analysts predict that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, expanding its regulated crypto offerings and potentially driving additional trading activity. CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: The new futures product is CME’s first market-cap weighted contract, which could broaden participation from both institutional and active retail traders. CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: Interactive Brokers also said it will integrate CME Group event contracts into a unified prediction-market platform, which may improve distribution and accessibility for CME-linked products. Interactive Brokers Rolls Out Centralized Prediction Market Trading Hub with Kalshi Partnership
• Neutral Sentiment: CME Group also released preliminary annual meeting results, including board elections, but the update appears routine and is unlikely to materially affect the stock. CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
• Neutral Sentiment: Recent analyst commentary remains moderately constructive, but does not appear to be the main driver of the move. Do Wall Street Analysts Like CME Group Stock?

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.